Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review
Yaping Chang, Romina Brignardello‐Petersen(Sylvester Comprehensive Cancer Center), Shaneela Shahid, Trevor Teich(Drexel University), Laura C. Michaelis(Medical College of Wisconsin), Jessica K. Altman(Northwestern University), Jamie L. Dawdy(McMaster University), Gordon Guyatt(Impact), Rena Buckstein(Sunnybrook Health Science Centre), Mikkael A. Sekeres(University of Miami), Christopher S. Hourigan(National Heart Lung and Blood Institute), Richard M. Stone(Dana-Farber Cancer Institute), Pinkal Desai(NewYork–Presbyterian Hospital), Mark R. Litzow(Mayo Clinic in Arizona), Thomas W. LeBlanc(Duke University), Janet MacEachern(Grand River Hospital), Gregory A. Abel(Dana-Farber Cancer Institute), Sudipto Mukherjee(Cleveland Clinic), Shabbir M.H. Alibhai(University Health Network)
Cited by 4
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.
|PubMed|1985|2.1k
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
|Journal of Allergy and Clinical Immunology|2017|2k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k